Zevra Therapeutics Inc (ZVRA)
7.75
-0.12
(-1.52%)
USD |
NASDAQ |
May 12, 16:00
7.75
0.00 (0.00%)
Pre-Market: 09:05
Key Stats
Price and Performance | |
---|---|
Market Cap | 419.40M |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | 60.79% |
Valuation | |
PE Ratio | -- |
PE Ratio (Forward) | Upgrade |
PS Ratio | 15.18 |
Price to Book Value | 10.57 |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | -- |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | 1.500 |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 99.27% |
Profile
Edit
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community. |
URL | https://www.zevra.com |
Investor Relations URL | https://investors.zevra.com/ |
HQ State/Province | Florida |
Sector | Health Care |
Industry | Pharmaceuticals |
Next Earnings Release | May. 13, 2025 |
Last Earnings Release | May. 13, 2025 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |
Ratings
Profile
Edit
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community. |
URL | https://www.zevra.com |
Investor Relations URL | https://investors.zevra.com/ |
HQ State/Province | Florida |
Sector | Health Care |
Industry | Pharmaceuticals |
Next Earnings Release | May. 13, 2025 |
Last Earnings Release | May. 13, 2025 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |